The secret life of tumours
In recent funding calls, IMI has turned its attention to emerging cancer therapies, seeking better understanding of things like the effect of tumour microenvironment on immunotherapy success
Site Search
Site Search
Displaying results 271 - 280 of 893
CANCER-ID hunts for cancer clues in blood samples
Today, many cancer patients have to undergo biopsy surgery to provide doctors with the cell samples they need to diagnose the disease and monitor how well a treatment is working. IMI’s CANCER-ID project has paved the way for the use of ‘liquid biopsies’ drawn from a blood sample ...
IMI2 - Call 21 (COVID-19) webinar
Please note IMI2 JU’s corrigendum (of 5 March 2020) addressing a clerical error on page 12 of a previous release of the IMI2 JU Call 21 Call for proposals document and confirming that applicants should submit a proposal with a page limit of 70 pages. About the webinar IMI held a ...
IMI planning EUR 45 million Call for proposals on COVID-19
The fast-track, single stage Call will cover therapeutics and diagnostics to tackle the outbreak of the novel coronavirus. IMI plans to launch a Call for proposals on COVID-19, the novel coronavirus that was first reported in China in December 2019 and has since infected over 71 ...
First batch of real-world data from prostate cancer studies added to big data platform
Partners in the PIONEER project have uploaded datasets from major studies, and are calling on others to do the same
New cancer therapies offer hope, but there’s still a lot we don’t know
If medicine developers are to invest heavily in immunotherapy, oncologists, authorities and insurers need clear guidance on who will benefit
PARADIGM: a ‘game changer’ for patient engagement in R&D
When and how should the health research and development community involve patients in their work? IMI’s PARADIGM project is trying to find out.
Identifying potential antibiotic leads is painfully slow, but these researchers identified 5 in only 6 years
ENABLE surpassed their goal of identifying 3 leads for new antibiotics. With more promising compounds in the pipeline, the project has been extended.
Cancer, tuberculosis and vaccines in new IMI Call for proposals
Brussels, Belgium, 21 January 2020 – Today, the Innovative Medicines Initiative (IMI) is launching a new Call for proposals with funding opportunities in cancer, tuberculosis, vaccines, psoriatic arthritis and drugs based on proteins. IMI2 – Call 20 has a total budget of EUR 273 ...